Lung cancer's high mortality rate necessitated palliative care and pain management to improve patients' quality of life.

From diagnosis methods to management of comorbid infections, new lung cancer protocols adaptable for various conditions ...

Please use one of the following formats to cite this article in your essay, paper or report: APA. Thomas, Liji. (2019, February 26). Palliative and End-of-Life Care in Lung Cancer.

Over the ensuing years, investigators published additional trials of in-person early palliative care that enrolled patients with advanced cancers, including lung cancer, with many confirming the ...

In 2004, an estimated 173,700 Americans will receive a diagnosis of lung cancer, and 164,440 of them will die of the disease. Despite years of research, the prognosis for patients with lung cancer ...

Having an understanding of the progression of lung cancer and the treatment methods helps the patients and their families to ...

Metastatic non-small cell lung cancer treatment and management requires a team effort. Here are the healthcare professionals to consider adding to your team. Metastatic non-small cell lung cancer ...

In conclusion, the COVID-19 pandemic has created a generational crisis and placed an unprecedented strain on health care resources and our ability to deliver high-quality seamless care for patients ...

Drs Jacob Sands and Jamie Chaft discuss the past, present, and future of perioperative management of lung cancer, including data from recent trials, disease-free survival outcomes, and changes in ...

Edgardo S. Santos, MD, FACP, FASCO, highlighted how liquid biopsies are transforming lung cancer care by enabling faster, less invasive diagnostics, with key applications in early detection ...

Nature - The biology and management of non-small cell lung cancer. ... (CTLA-4) and antibodies against PD-1 or PD-L1 have signalled a new direction for lung cancer care.

Panelists discuss how atezolizumab is being investigated in the NRG-LU005 trial for limited-stage small cell lung cancer (SCLC), comparing its trial design with that of the ADRIATIC study, while ...